Association between immune-related adverse events and clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis

被引：0
|
作者：
Chen, J. [1 ]
Zhang, Y. [1 ]
Ni, Y. [1 ]
Sun, G. S. [1 ]
Zeng, H. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Urol, Chengdu, Peoples R China
来源：
EUROPEAN UROLOGY | 2022年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0386
引用
收藏
页码：S598 / S598
页数：1
相关论文
共 50 条
  • [1] ASSOCIATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND CLINICAL OUTCOMES IN ADVANCED GENITOURINARY CANCERS TREATED WITH IMMUNOTHERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Chen, Junru
    Zhang, Yaowen
    Ni, Yuchao
    Sun, Guangxi
    Zeng, Hao
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1023 - E1023
  • [2] Immune-related adverse events (irAEs) and the association with clinical outcomes in advanced genitourinary cancers treated with immunotherapy: A systematic review and meta-analysis.
    Zhang, Yaowen
    Chen, Junru
    Sun, Guangxi
    Zhang, Xingming
    Zeng, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 431 - 431
  • [3] Immune-related adverse events and efficacy outcomes in patients treated with immunotherapy: A systematic review and meta-analysis
    Druyts, Eric
    Boye, Mark
    Agg, Himani
    Muehlenbein, Catherine
    Frederickson, Andrew
    Bayt, Theresa
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [4] The association between immune-related adverse events and the prognosis of solid cancer patients treated with immunotherapy: a systematic review and meta-analysis
    Xu, Huilin
    Xu, Ximing
    Ge, Wei
    Lei, Jinju
    Cao, Dedong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [5] Sarcopenia as biomarker for immunotherapy outcomes and immune-related adverse events - a systematic review and meta-analysis
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, Cordas D.
    Theurich, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 228 - 228
  • [6] SARCOPENIA AS BIOMARKER FOR IMMUNOTHERAPY OUTCOMES AND IMMUNE-RELATED ADVERSE EVENTS - A SYSTEMATIC REVIEW AND META-ANALYSIS
    Guenther, S.
    Trinkner, P.
    von Bergwelt, M.
    dos Santos, D. Cordas
    Theurich, S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A7 - A7
  • [7] Management and Outcomes of Hematological Immune-related Adverse Events: Systematic Review and Meta-analysis
    Wilson, Nathaniel R.
    Lockhart, Jonathan R.
    Garcia-Perdomo, Herney A.
    Oo, Thein H.
    Rojas-Hernandez, Cristhiam M.
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 13 - 24
  • [8] The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis
    Zhang, Yaowen
    Chen, Junru
    Liu, Haoyang
    Dai, Jindong
    Zhao, Junjie
    Zhu, Sha
    Zhang, Xingming
    Liang, Jiayu
    Hu, Xu
    Zhao, Jinge
    Liu, Zhenhua
    Shen, Pengfei
    Sun, Guangxi
    Zeng, Hao
    CANCER TREATMENT REVIEWS, 2024, 129
  • [9] Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
    Pasello, Giulia
    Pavan, Alberto
    De Nuzzo, Mattia
    Frega, Stefano
    Ferro, Alessandra
    Dal Maso, Alessandro
    Bonanno, Laura
    Guarneri, Valentina
    Girardi, Fabio
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [10] Endocrine immune-related adverse events (irAEs) of combined immunotherapy in solid tumors: Systematic review and meta-analysis
    Tsoukalas, N. G.
    Tsitsimpis, A.
    Katsouda, A.
    Arvanitou, E.
    Bagos, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S845 - S845
12345